{
  "meta": {
    "id": "test12",
    "title": "Psychiatry - INI CET NOV 2023",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Consider the following statements: contemplation \u2013 a person who thinks of quitting smoking but is not sure. pre-contemplation \u2013 a person considers to start morning walk. maintenance \u2013 a person has quit smoking one year back & has not smoked since them. Action phase \u2013 a person says that he cannot quit smoking as he is addicted to it. (sub-psychiatry) Select the correct answer from the given below code:",
      "options": [
        {
          "label": "A",
          "text": "Statement 1 & 3 are correct",
          "correct": true
        },
        {
          "label": "B",
          "text": "Statement 1 & 2 are correct",
          "correct": false
        },
        {
          "label": "C",
          "text": "Statement 1,2 & 3 are correct",
          "correct": false
        },
        {
          "label": "D",
          "text": "All statements are correct",
          "correct": false
        }
      ],
      "correct_answer": "A. Statement 1 & 3 are correct",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Statement 1 & 3 are correct According to the stages of motivation, statement 1 & 3 are correct.</p>\n<p><strong>Highyeild:</strong></p><p>The \u201cstages of change\u201d or \u201ctranstheoretical\u201d model is a way of describing the process by which people overcome addiction. Those stages\u2014 Precontemplation (i.e., not yet considering change), Contemplation (i.e., considering change but not taking action), Preparation (i.e., planning to change), action (i.e., making changes in one\u2019s behavior), and Maintenance (i.e., changing one\u2019s lifestyle to maintain new behavior)\u2014offer a new perspective on motivation and the process of behavior change.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Goals for MET Sessions Session Goal Session 1 (week 1) Provide personalized feedback from assessment instruments; identify and address ambivalence; build motivation for change Session 2 (week 2 or 3) Develop a change plan; strengthen commitment to change Sessions 3 and 4 (weeks 6 and 12) Review progress on the change plan; renew motivation; termination of therapy</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2d94b4fa",
      "audio": ""
    },
    {
      "text": "A pregnant female with bipolar disorder came to the clinic in the third trimester. She has had 4 episodes in the past and is stable on lithium 750 mg/day since 1 year during which time she has not had any episodes. What is the next best step in management?",
      "options": [
        {
          "label": "A",
          "text": "Stop lithium and let her be drug free",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decrease lithium dosage",
          "correct": true
        },
        {
          "label": "C",
          "text": "Increase lithium dosage",
          "correct": false
        },
        {
          "label": "D",
          "text": "Switch to valproate",
          "correct": false
        }
      ],
      "correct_answer": "B. Decrease lithium dosage",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Decrease lithium dosage Ideally, we should continue the same dose of Lithium. But among the give options, the best answer is B.</p>\n<p><strong>Highyeild:</strong></p><p>Lithium is a first-line drug for the treatment of bipolar disorders However, its use is limited by numerous adverse effects: Lithium may induce or worsen pre-existing hypothyroidism by blocking the production and release of L-thyroxine It is a teratogen (increased risk of congenital heart defects like Ebstein anomaly) It may cause lithium nephropathy or worsen chronic kidney disease. Therefore, pregnancy should be ruled out and kidney and thyroid function should be assessed before beginning treatment.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A \u2013 mood stabilizers can\u2019t be stopped abruptly Option: C- increases risk of Li toxicity in 3 rd Option: D- mood stabilizers shouldn\u2019t be changed suddenly if the patient is stable and responsive to the current drug.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Lithium in Bipolar</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4c59d210",
      "audio": ""
    },
    {
      "text": "A patient on amitriptyline was found in an unconscious state. Which of the following does not suggest amitriptyline toxicity?",
      "options": [
        {
          "label": "A",
          "text": "Confusion / altered sensorium",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypothermia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Arrythmia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dilated pupil",
          "correct": false
        }
      ],
      "correct_answer": "B. Hypothermia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Hypothermia The patient is suffering from T.C.A toxicity.</p>\n<p><strong>Highyeild:</strong></p><p>Amitriptyline is a tricyclic antidepressant indicated in the treatment of depressive illness, either endogenous or psychotic, and to relieve depression associated anxiety. Features of TCA toxicity are \u2013 Altered sensorium Cardiac arrhythmia Seizures Respiratory suppression Dilated pupils Blurring of vision Dryness of mouth Hyperthermia instead of hypothermia is most likely to be seen.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "614ee395",
      "audio": ""
    }
  ]
}